efavirenz and Bilateral Headache

efavirenz has been researched along with Bilateral Headache in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chonzi, P; Dhoro, M; Kadzirange, G; Masimirembwa, C; Ngara, B; Nhachi, C; Zvada, S1
Auger, P; Di Spirito, M; Fan, L; Iwamoto, M; Khalilieh, SG; Lai, MT; Liu, R; Sanchez, RI; Triantafyllou, I; Yee, KL1
Bannister, WP; Beniowski, M; Burger, DM; Castagna, A; Di Perri, G; Karlson, A; Lundgren, JD; Mocroft, A; Molto, J; Peytavin, G; Reiss, P; van Luin, M1

Trials

1 trial(s) available for efavirenz and Bilateral Headache

ArticleYear
Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Female; Headache; Healthy Volunteers; Humans; Male; Middle Aged; Pyridones; Triazoles

2017

Other Studies

3 other study(ies) available for efavirenz and Bilateral Headache

ArticleYear
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.
    BMC pharmacology & toxicology, 2015, Mar-27, Volume: 16

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Alleles; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Body Weight; Case-Control Studies; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Female; Hallucinations; Headache; Humans; Male; Models, Biological; Rifampin; Sex Characteristics; Sleep Wake Disorders; Tuberculosis; Zimbabwe

2015
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.
    Antiviral therapy, 2009, Volume: 14, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Europe; Female; Headache; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Risk Factors; Sleep Initiation and Maintenance Disorders

2009
Three new drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 1998, Dec-04, Volume: 40, Issue:1041

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Dideoxynucleosides; Dizziness; Drug Therapy, Combination; Headache; HIV Infections; Humans; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors

1998